Drug 'shrinks lung cancer tumour'

[E. Nigma]

-----BEGIN PGP SIGNED MESSAGE-----

Scientists have identified a drug which may offer hope to patients
with a particularly lethal form of lung cancer.

The drug eliminated small cell lung cancer tumours in 50% of mice,
and blocked the cells' ability to resist standard chemotherapy
treatment.

The Imperial College London team now hope to test it in patients with
an inoperable form of the disease.

Their study appears in the journal Cancer Research.

� We hope to take this drug into clinical trials next year �
Professor Michael Seckl Imperial College London

Lung cancer is a major killer, and the small cell version of the
disease, which makes up 20% of total cases, has a particularly poor
prognosis. Only around 3% of patients survive for five years.

The cancer spreads quickly, so surgery is not often an option.

Chemotherapy, sometimes supplemented with radiotherapy, often reduces
the size of tumours, but they usually grow back rapidly, and become
resistant to further treatment.

A growth hormone called FGF-2 appears to speed division of the cancer
cells, and to trigger a survival mechanism which makes them resistant
to chemotherapy.

PD173074 blocks FGF-2 from attaching to tumour cells. The researchers
say it could potentially be taken as a pill, rather than fed into the
body via a drip.

It was originally developed in 1998 to stop blood vessels from
forming around tumours.

Further trials needed

Researcher Professor Michael Seckl said: "We urgently need to develop
new treatments for this disease.

"We hope to take this drug, or a similar drug that also stops FGF-2
from working, into clinical trials next year to see if it is a
successful treatment for lung cancer in humans."

Initially, the new drug was tested on cells taken from human tumours.

It stopped the cells proliferating, and neutralised their defences,
allowing them to be killed off with standard chemotherapy.

Follow-up tests on mice showed the drug was effective against tumour
cells, both in isolation, and in combination with the standard
chemotherapy agent, cisplatin.

Dr Joanna Owens, of the charity Cancer Research UK, said: "It is
encouraging to see potential new drugs for lung cancer in the initial
stages of development.

"The early results from this study are impressive but we will need to
wait for the results of clinical trials before we will know if the
drugs could work for patients."

Story from BBC NEWS:
http://news.bbc.co.uk/go/pr/fr/-/2/hi/health/8350220.stm

===========

E.

-----BEGIN PGP SIGNATURE-----
Version: PGP Personal Privacy 6.5.3

iQEVAwUBSvnkBNAqdZr/mrO9AQEOeAf8CjDfPDJ4SyF1sfuabTuOFb34FdxsPg5O
y/fqKm8IcOqJBxvkzNpzoqA/kqY7bcqBHKlBMwU/U8pJxpwjL6nyKPCsMvhkNPQq
ofAbOQr0DA+MKUqyxkVXme1jfsEK6ad34W+9cJnX7G+oOspub0wFj4LGMzKzmlQ2
/q+l9r1DIz3vpWz5lXPqMdqobfUVeMe9ylXNYKGPzRhNzrJlKJZa8qouu2Uf2247
UEdHe0rybtvEVpM7bAXoWyK6sH2fCLF7xei3hQVvI8UYq1AFJanvMJmwJiwbDFTR
6ayKDegtcsbLZrbB76EE2LmKbsy2F5ZeZQKuuEWDbrbmqirJN6QCYw==
=O6He
-----END PGP SIGNATURE-----